PET study of competition between intravenous cocaine and [11C]raclopride at dopamine receptors in human subjects

American Journal of Psychiatry

Volumn 154, Issue 9, 1997, Pages 1209-1213

  Schlaepfer, Thomas E ^a   Pearlson, Godfrey D ^b   Wong, Dean F ^b   Marenco, Stefano ^b   Dannals, Robert F ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 11; COCAINE; DOPAMINE RECEPTOR; RACLOPRIDE;

ADULT; ARTICLE; BINDING COMPETITION; CLINICAL ARTICLE; DRUG RECEPTOR BINDING; EUPHORIA; HUMAN; INTRAVENOUS DRUG ABUSE; ISOTOPE LABELING; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 0030799746     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.154.9.1209     Document Type: Article

References (30)

1. Anthony JC: Epidemiological research on cocaine use in the USA. Ciba Found Symp 1992; 166:20-33
2. Freud S: Üer Coca. Zentralblatt für die Gesamte Therapic 1885; 2:289-314
3. Kornetsky C, Esposito RU, McLean S, Jacohson JO: Intracranial self-stimulation thresholds: a model for the hedonic effects of drugs of abuse. Arch Gen Psychiatry 1979; 36:289-292
4. Spealman RD, Madras BK, Bergman J: Effects of cocaine and related drugs in nonhuman primates, II: stimulant effects on schedule-controlled behavior. J Pharmacol Exp Ther 1989; 251: 142-149
5. Griffiths RR, Brady JV, Bigelow GE: Predicting the dependence liability of stimulant drugs. NIDA Res Monogr 1981; 37:182-196
6. Nicholi AJ: The nontherapeutic use of psychoactive drugs: a modern epidemic. N Engl J Med 1983; 308:925-933
7. Ritz MC, Kuhar MJ: Psychostimulant drugs and a dopamine hypothesis regarding addiction: update on recent research. Biochem Soc Symp 1993; 39:51-64
8. McMillan BA: CNS stimulants: two distinct mechanisms of action for amphetamine-like drugs. Trends Pharmacol Sci 1983; 4:429-432
9. Bozarth MA: New perspectives on cocaine addiction: recent findings from animal research. Can J Physiol Pharmacol 1989; 67: 1158-1167
10. Kuhar MJ, Ritz MC, Boja JW: The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 1991; 14: 299-302
11. Kuhar MJ: Molecular pharmacology of cocaine: a dopamine hypothesis and its implications. Ciba Found Symp 1992; 166:81-89
12. Farde L, Nordstrom AL, Wiesel FA, Pauli S, Halldin C, Sedvall G: Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine: relation to extrapyramidal side effects. Arch Gen Psychiatry 1992; 49:538-544
13. Young LT, Wong DF, Goldman S, Minkin E, Chen C, Matsumura K, Scheffel U, Wagner HN: Effects of endogenous dopamine on kinetics of [3H]N-methylspiperone and [3H]raclopride binding in the rat brain. Synapse 1991; 9:188-194
14. Seeman P, Niznik HB, Guan H-C: Elevation of dopamine D2 receptors in schizophrenia is underestimated by radioactive raclopride. Arch Gen Psychiatry 1990; 47:1170-1172
15. Volkow ND, Wang GJ, Fowler JS, Logan J, Schlyer D, Hitzemann R, Lieberman J, Angrist B, Pappas N, Macgregor R, Burr G, Cooper T, Wolf AP: Imaging endogenous dopamine competition with (11C)raclopride in the human brain. Synapse 1994; 16:255-262
16. Pearlson GD, Jeffery PJ, Harris GJ, Ross CA, Fischman MW, Camargo EE: Correlation of acute cocaine-induced changes in local cerebral blood flow with subjective effects. Am J Psychiatry 1993; 150:495-497
17. Fischman MW, Schuster CR, Resnekov L, Shick JF, Krasnegor NA, Fennell W, Freedman DX: Cardiovascular and subjective effects of intravenous cocaine administration in humans. Arch Gen Psychiatry 1976; 33:983-989
18. Fibiger HC, Phillips AG, Brown EE: The neurobiology of cocaine-induced reinforcement. Ciba Found Symp 1992; 166:96-111
19. Pulvirenti L, Koob GF: Dopamine receptor agonists, partial agonists and psychostimulant addiction. Trends Pharmacol Sci 1994; 15:374-379
20. Koob GF: Neurobiological mechanisms in cocaine and opiate dependence. Res Publ Assoc Res Nerv Ment Dis 1992; 70:79-92
21. Holman RB: Biological effects of central nervous system stimulants. Addiction 1994; 89:1435-1441
22. Kiyatkin HA: Dopamine mechanisms of cocaine addiction. Int J Neurosci 1994; 78:75-101
23. Gawin FH, Ellinwood EH Jr: Cocaine and other stimulants: actions, abuse, and treatment. N Engl J Med 1988; 318:1173-1182
24. Malison RT, Best SF, Wallace EA, McCance E, Laruelle M, Zoghbi SS, Baldwin RM, Seibyl JS, Hoffer PB, Price LH, Kosten TR, Innis RB: Euphorigenic doses of cocaine reduce [123I]beta-CIT SPECT measures of dopamine transporter availability in human cocaine addicts. Psychopharmacology (Berl) 1995; 122:358-362
25. Koob G, Caine B, Markou A, Pulvirenti L, Weiss F: Role for the mesocortical dopamine system in the motivating effects of cocaine. NIDA Res Monogr 1994; 145:1-18
26. Gong W, Neill D, Justice J: Conditioned place preference and locomotor activation produced by injection of psychostimulants into ventral pallidum. Brain Res 1996; 707:64-74
27. Goldfrank LR, Hoffman RS: The cardiovascular effects of cocaine. Ann Emerg Med 1991; 20:165-175
28. Klonoff DC, Andrews BT, Obana WG: Stroke associated with cocaine use. Arch Neurol 1989; 46:989-993
29. Woolverton WL, Johnson KM: Neurobiology of cocaine abuse. Trends Pharmacol Sci 1992; 13:193-200
30. Volkow ND, Fowler JS, Wolf AP, Hitzemann R, Dewey S, Bendriem B, Alpert R, Hoff A: Changes in brain glucose metabolism in cocaine dependence and withdrawal. Am J Psychiatry 1991; 148:621-626